Oncology target selection remains remarkably qualitative. At Bio-IT World 2026, our CEO Andreas Stuhlmüller shared how we're thinking about this problem. Watch the full talk: youtu.be/rTou2fsDwMc.
youtube.comFrom Literature Search to Living Model: Causal Reasoning for Oncology Target NominationDespite billions in R&D investment, oncology target selection remai...